-
Protease Inhibitor Cocktail for NPC Protein Assays
2026-08-28
Discover how a Protease Inhibitor Cocktail improves protein degradation prevention in DHODH–TP53 studies of nasopharyngeal carcinoma. This guide connects protease control with Western blot, co-immunoprecipitation, and mechanistic assay interpretation.
-
Hoechst 33258: Reading Tumor pH Responses in DNA
2026-08-28
A translational framework for using Hoechst 33258 as a nuclear and DNA-content readout alongside tumor pH-modulating therapies, with practical guidance on assay design, controls, limitations, and reproducibility.
-
Protease Inhibitor Cocktail: EDTA-Free Workflow
2026-08-27
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic loss during protein extraction and downstream analysis while avoiding added EDTA. It is suited to phosphorylation-sensitive and protein-interaction workflows, but should be validated or omitted when the assay directly measures protease activity.
-
circ_0042103/TAF15/NER Axis in Pulpitis
2026-08-27
The reference study identifies a circ_0042103/TAF15/NER regulatory axis that links circular RNA activity with DNA damage and inflammatory signaling in dental pulp stem cells. Its integrated tissue, sequencing, molecular interaction, and perturbation experiments suggest that impaired nucleotide excision repair contributes to pulpitis progression, while also defining practical considerations for circular RNA validation.
-
Ciclopirox Bioenergetics and ER Stress in NSCLC
2026-08-26
Lu and colleagues show that the repurposed antifungal ciclopirox suppresses non-small cell lung cancer through coordinated disruption of cellular bioenergetics, reactive oxygen species accumulation, ER stress, and apoptosis. The study connects metabolic dysfunction with reduced migration and tumor growth, while also illustrating how integrated cell-based and xenograft assays can clarify drug-repositioning mechanisms.
-
Nifedipine (BAY-a-1040) Research Workflows
2026-08-26
Build reproducible calcium, iron, fungal, and liver-pharmacology assays with Nifedipine (BAY-a-1040). This practical guide combines concentration-controlled workflows, reference-study insights, and troubleshooting strategies for separating calcium influx inhibition from broader metabolic adaptation.
-
Cholesterol Hinders LNP Intracellular Trafficking
2026-08-25
A 2025 International Journal of Pharmaceutics study developed a streptavidin–biotin-DNA tracking platform with high-throughput imaging to resolve how lipid nanoparticle composition affects intracellular routing. The data identify elevated cholesterol as a driver of peripheral early-endosome aggregation, which restricts endolysosomal progression and reduces access to compartments associated with nucleic acid release.
-
Shrimp Epigenetics and Vesicles After Vibrio Priming
2026-08-25
This exploratory study examines how inactivated Vibrio parahaemolyticus priming affects histone modifications and small extracellular vesicles in Penaeus vannamei hemocytes. Its main contribution is the identification of a rapid, dose-dependent, and largely reversible chromatin response, alongside preliminary evidence that hemolymph vesicle profiles may change after immune stimulation.
-
Shrimp Epigenetics and Vesicles After Vibrio Priming
2026-08-24
A March 2026 study in Penaeus vannamei provides time-resolved evidence that inactivated Vibrio parahaemolyticus produces transient, dose-dependent changes in hemocyte H3K4me3 and H3K27me3, alongside preliminary small extracellular vesicle observations. The work establishes a useful baseline for studying shrimp trained innate immunity while emphasizing that vesicle findings and epigenetic persistence require further validation.
-
L-NMMA acetate for NO Pathway Assays
2026-08-24
L-NMMA acetate enables controlled, pan-NOS inhibition for testing whether nitric oxide signaling drives osteogenic differentiation, inflammatory responses, or other cell phenotypes. This practical workflow connects dose-response design, orthogonal pathway readouts, and troubleshooting to the dental follicle cell findings reported for puerarin.
-
Candida auris Antifungal Pipeline: Review Findings
2026-08-23
This systematic review maps the emerging antifungal pipeline for multidrug-resistant Candida auris by integrating in vitro susceptibility data with efficacy findings from neutropenic animal models. Its main contribution is a comparative framework showing how agents such as manogepix/fosmanogepix, ibrexafungerp, rezafungin, and tetrazoles including Oteseconazole and VT-1598 may expand treatment options while remaining at different stages of validation.
-
MDL 28170: A Practical Calpain Inhibitor Workflow
2026-08-22
MDL 28170 combines nanomolar calpain inhibition with cathepsin B activity and membrane permeability, making it useful for mechanistic neuroprotection research, apoptosis assays, and cell-based injury models. This guide translates recent BDNF/TrkB findings into practical assay design, dosing controls, and troubleshooting strategies.
-
AI-10-49: Mapping RUNX1 Recovery in inv(16) AML
2026-08-22
AI-10-49 is a selective CBFβ-SMMHC inhibitor that enables more than leukemia cell growth studies. This guide presents an assay-centered strategy for connecting fusion-protein disruption with RUNX1 chromatin recovery and the N-MYC/eIF4G1 survival program in inv(16) AML.
-
TET2 Metabolite Binding: A Practical STD NMR Protocol
2026-08-21
This 2025 STAR Protocols paper presents an integrated workflow that combines biochemical TET2 activity assays with saturation transfer difference NMR to distinguish metabolite binding from functional regulation. The protocol validates known TET2 activators and inhibitors and provides a route for identifying additional regulatory metabolites, including glyoxylate.
-
TG003 Cdc2-like Kinase Inhibitor Workflows
2026-08-20
TG003 connects reversible Clk-family inhibition with practical assays for alternative splicing, exon-skipping research, and platinum-resistance biology. This workflow-focused guide covers stock preparation, orthogonal readouts, isoform-aware interpretation, and troubleshooting for more reproducible experiments.